Oral Rehydration Therapy: Implementation Issues in Community-Based Distribution Programs

Author(s):  
Maria J. Wawer
Author(s):  
Ted Lankester

This chapter discusses diseases that commonly kill children. It covers, causes, priorities, and community-based and clinic programmes, including immunization and the Integrated Management of Childhood Illness (IMCI). It emphasizes ways in which diarrhoea, pneumonia, and malaria can be managed at community and family level. It highlights the dangers and types of diarrhoea, its causes, and treatment. It includes a detailed section on dehydration and oral rehydration therapy (ORT and ORS), appropriate rehydrating foods, and how these can be embedded into use by families. It describes acute respiratory infection (ARI), its causes, prevention, diagnosis, and treatment. Importantly, it describes how community health workers (CHWs) and community members can assess ARI severity and how it can be best treated, including the careful use of community-based and home-based antibiotics in remoter areas. Finally, the chapter addresses malaria diagnosis and treatment, particularly how a community can set up a step-by-step control programme.


The Lancet ◽  
1979 ◽  
Vol 314 (8147) ◽  
pp. 809-812 ◽  
Author(s):  
M. Mujibur Rahaman ◽  
Yakub Patwari ◽  
K.M.S. Aziz ◽  
M.H. Munshi

2001 ◽  
Vol 77 (6) ◽  
pp. 481-6
Author(s):  
Lauro Virgílio de Sena ◽  
Helcio de S. Maranhão ◽  
Mauro B. Morais

2021 ◽  
Vol 6 (1) ◽  
pp. 34
Author(s):  
David Nalin

The original studies demonstrating the efficacy of oral glucose-electrolytes solutions in reducing or eliminating the need for intravenous therapy to correct dehydration caused by acute watery diarrheas (AWD) were focused chiefly on cholera patients. Later research adapted the oral therapy (ORT) methodology for treatment of non-cholera AWDs including for pediatric patients. These adaptations included the 2:1 regimen using 2 parts of the original WHO oral rehydration solution (ORS) formulation followed by 1 part additional plain water, and a “low sodium” packet formulation with similar average electrolyte and glucose concentrations when dissolved in the recommended volume of water. The programmatic desire for a single ORS packet formulation has led to controversy over use of the “low sodium” formulations to treat cholera patients. This is the subject of the current review, with the conclusion that use of the low-sodium ORS to treat cholera patients leads to negative sodium balance, leading to hyponatremia and, in severe cases, particularly in pediatric cholera, to seizures and other complications of sodium depletion. Therefore it is recommended that two separate ORS packet formulations be used, one for cholera therapy and the other for non-cholera pediatric AWD.


1983 ◽  
Vol 74 (5) ◽  
pp. 335-341 ◽  
Author(s):  
Jay Swedberg ◽  
Joseph F. Steiner

2017 ◽  
Vol 36 (3) ◽  
pp. 250-255 ◽  
Author(s):  
Dillip Kumar Dash ◽  
Mrutunjaya Dash ◽  
M.D. Mohanty ◽  
Naresh Acharya

Introduction: Administration of S. boulardii in addition to rehydration therapy in diarrhea found to be beneficial in many aspects owing to a variety of causes and importantly it is was not associated with any adverse effects.Material and Methods: We conducted a prospective study of children suffering from acute diarrhoea, at a private tertiary care hospital. Children were divided into 2 groups randomly as per odd(Group 1 ) and even (Group 2) bed allotted in indoor at the time of admission: Group 1 included children on oral rehydration therapy (ORT) + Zinc + Saccharomyces boulardii (Probiotic 5 billion CFU twice daily) and Group 2 comprised of children on ORT+ Zinc. Our objective was to systematically review data on the effect of S. boulardii on acute childhood diarrhoea.Results: Out of a total of 126 children less than 2 years, 2-6 years and 6-14 years were 72 (57.14%), 42(33.33%) and 12(09.52%) respectively. The duration of diarrhoea in Group 1 was 26.31 hours and Group 2 was 47.81 hours (p<0.01). The frequency of diarrhoea showed improvement within 24 and 72 hours in Group 1 and Group 2 respectively (p<0.01).Similarly, the mean duration of hospital stay was 2.68 days in Group 1 and 4.8 days in Group 2.The treatment cost was INR 850 and INR 1650 while social cost was INR 1250 and 2600 in Group 1 and 2 respectively.Conclusion:This study shows that S. boulardii reduced the duration, frequency and hospital stay of diarrhoea thereby reducing the treatment and social costs.J Nepal Paediatr Soc 2016;36(3):250-255


Sign in / Sign up

Export Citation Format

Share Document